SEC Form 4 · accession 0001193805-17-001298
ADMA BIOLOGICS, INC. · ADMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric I Richman
Director
Period of report
Jul 13, 2017
Accepted (ET)
Jul 17, 2017 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001368514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 13, 2017 | M | 2,800 | $2.68 | A | 6,300 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.68 | Jul 13, 2017 | M | 2,800 | D | — | Jul 16, 2017 | Common Stock | 2,800 | 0 | D |
Explanation of responses
- F1The shares subject to the option vested in equal monthly installments over the four (4) year period following July 16, 2007.